IP Library › Granted Patent US 8,987,214
Granted Patent B2
US 8,987,214 · App. 14/507,267 · Granted Mar 24, 2015

Solid compositions

Inventors: Yi Gao (Vernon Hills, IL); Geoff Zhang (Vernon Hills, IL)
Assignee: AbbVie Inc.
A61K9/10A61K31/4184A61K47/32A61K38/06A61K38/05A61K38/07A61K45/06A61K9/146A61K9/1635A61K31/403A61K31/4178A61K31/439A61K31/4709A61K31/497A61K31/501A61K31/519A61K31/549A61K31/55A61K31/7068A61K31/708
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,987,214
App. No.
14/507,267
Granted
Mar 24, 2015
Kind
B2
Abstract

The present invention features solid compositions comprising a selected HCV inhibitor in an amorphous form. In one embodiment, the selected HCV inhibitor is formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.

Claims (3)

1. A solid oral dosage form comprising a solid solution which includes:

copovidone, and

optionally a pharmaceutically acceptable surfactant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2015
From: GAO, YI; ZHANG, GEOFF
To: ABBVIE INC.
Reel/Frame 034802/0666 →
Continuity (4)
Continuation In Part 13717993 · Dec 18, 2012
Provisional Application 61581146 · Dec 29, 2011
Provisional Application 61645696 · May 11, 2012
Related Publication 20150025024A1 · Jan 22, 2015